Antibiotic boosts chemo against tough pancreatic cancer?
NCT ID NCT04523987
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether adding the antibiotic ciprofloxacin to standard chemotherapy can help control metastatic pancreatic cancer. Ten patients who have not had prior treatment will receive the combination. The main goal is to see if the tumors shrink or stop growing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National University Hospital
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart drug delivers chemo directly to pancreatic cancer cells
- Engineered T-Cells take aim at Hard-to-Treat pancreatic cancer
- Could a stomach drug help fight pancreatic cancer?
- New hope for tough pancreatic cancer? drug combo targets KRAS mutations
- Experimental vaccine combo takes on tough pancreatic cancer
- Supercharged immune cells take on Hard-to-Treat pancreatic cancer